EPO granted patent EP3355983A1 to Microoptx Inc. for dry eye treatment devices and methods invented by J. David Brown. The patent covers medical devices and methods for treating dry eye conditions, classified under A61K (medicinal preparations), A61F (prostheses), A61M (devices for introducing media), and A61L (materials for prostheses). The patent provides exclusive rights across all 36 designated contracting states including major European markets.

Patent holders should verify their Freedom-to-Operate status if developing similar dry eye treatment technologies. Competitors should conduct patent landscape analysis to identify potential licensing needs. Healthcare providers using dry eye treatment devices should ensure products are properly licensed. This is a routine patent publication with no immediate compliance actions required.